Gary Sender Net Worth & Insider Trades
Gary Sender - Chief Financial Officer, Nabriva Therapeutics Plc
What is Gary Sender's Net Worth?
The current estimated net worth of Nabriva Therapeutics Plc's Chief Financial Officer, Gary Sender, is estimated to be about $1.92M . Gary Sender owns about 6,200 units of Nabriva Therapeutics Plc common stock. In the last 4 years at Nabriva Therapeutics Plc, Gary Sender has sold an estimated value of $17.37K worth.
What is Gary Sender's Past Insider Trading?
Gary Sender's largest purchase order was 2,000 units , worth over $16.42K on September 26, 2017. In total, Gary Sender has made about 23 transactions over 4 years of their time at Nabriva Therapeutics Plc. Gary Sender usually trades in February, with the busiest year in 2020. The most recent transaction was a purchase order of 2,000 units , worth over $9.14K on May 23, 2018.
Gary Sender
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Gary Sender's' Mailing Address?
- Mailing address is C/o Synergy Pharmaceuticals Inc. 420 Lexington Ave New York NY 10020 NY
Nabriva Therapeutics Plc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Theodore Schroeder | 2020 | $576,800 | - | $242,256 | $339,625 | $242,256 | $31,759 | $1,654,570 |
| Theodore Schroeder | 2019 | $560,000 | - | $119,250 | $478,367 | $119,250 | $28,372 | $1,496,164 |
| Steven Gelone | 2020 | $486,300 | - | $153,185 | $231,493 | $153,185 | $12,675 | $1,154,516 |
| Steven Gelone | 2019 | $472,100 | - | $181,420 | $309,859 | $181,420 | $13,976 | $1,178,280 |
| Jennifer Schranz | 2020 | $460,000 | $100,000 | $145,203 | $156,818 | $145,203 | $28,604 | $1,074,113 |
| Jennifer Schranz | 2019 | $436,200 | - | $151,200 | $261,555 | $151,200 | $33,450 | $982,155 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1641640/000110465921088033/tm2119969-2_def14a.htm
What are Nabriva Therapeutics Plc's Past Insider Trades?
Nabriva Therapeutics Plc's most recent insider trade came on August 4, 2022 by Daniel Burgess who sold 11,341 units worth $2.16K . In the last 5 years, insiders at Nabriva Therapeutics Plc have sold an estimated value of $5.26M and bought an estimated value of $1.22M worth of shares. Insider trading is most common in August, with the busiest year in 2021. The most active traders at the company are Steven Gelone, Director, Theodore Schroeder, Director, and Robert Crotty, Gen Counsel & Corp Secretary .
Nabriva Therapeutics Legacy plc Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||